GangaGen, Inc. is a biotechnology company focused on the development of products for the prevention and treatment of bacterial infections, particularly infections that are resistant to antibiotics, through the application of contemporary molecular and clinical sciences. The Company's technology has arisen from its studies of bacteriophage, nature’s antibiotics.
Elusys Therapeutics is developing new biotherapeutic products that dramatically improve treatment of life-threatening infectious disease. Anthrax remains the number one bioterrorism threat. Development of effective new therapies are essential to
protect Americans.
TARIS Biomedical is building a world-class specialty pharmaceutical company focused on providing powerful new treatments to the millions of patients suffering from bladder diseases. We are advancing therapies for debilitating conditions, including bladder cancer and overactive bladder, enabled by continuous local dosing where it is needed.